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This communication describes the general characteristics of the venom from the Brazilian scorpion Tityus
fasciolatus, which is an endemic species found in the central Brazil (States of Goias and Minas Gerais),
being responsible for sting accidents in this area. The soluble venom obtained from this scorpion is toxic
to mice being the LD50 is 2.984 mg/kg (subcutaneally). SDS-PAGE of the soluble venom resulted in 10
fractions ranged in size from 6 to 10e80 kDa. Sheep were employed for anti-T. fasciolatus venom serum
production. Western blotting analysis showed that most of these venom proteins are immunogenic.
T. fasciolatus anti-venom revealed consistent cross-reactivity with venom antigens from Tityus serrulatus.
Using known primers for T. serrulatus toxins, we have identiﬁed three toxins sequences from T. fasciolatus
venom. Linear epitopes of these toxins were localized and ﬁfty-ﬁve overlapping pentadecapeptides
covering complete amino acid sequence of the three toxins were synthesized in cellulose membrane
(spot-synthesis technique). The epitopes were located on the 3D structures and some important residues
for structure/function were identiﬁed.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Tityus fasciolatus is an endemic species found in central Brazil
(Goias) and part of Minas Gerais (Minas Triangle), being responsible
for many cases of accidents in this area (Lourenço, 1995, 2003).
Tityus serrulatus (yellow scorpion), Tityus bahiensis (scorpion-
brown), Tityus stigmurus (yellow scorpion-of-northeast) and Tityus
obscurus (black scorpion-the-amazon) are the main species of the
genus Tityus of public health importance in Brazil (Ministry of
Health (2011)). The T. serrulatus and T. bahiensis are considered
the most common species responsible for the vast majority of
scorpion stings in Brazil (Ministry of Health (2011)). However, in
Brazilian Northeast, T. stigmurus was responsible for 51.2% ofica e Imunologia, Instituto de
erais, Belo Horizonte, Brazil.
lortegui).scorpion accidents (Lira-da-Silva et al., 2000). In Northern region,
all scorpions causing accidents are identiﬁed as T. obscurus (Pardal
et al., 2003).
The scorpion venom is a complex mixture composed of many
basic proteins of low molecular mass, amino acids, inorganic salts,
lipids, nucleotides and biogenic amines. Generally, it lacks proteo-
lytic activity, hemolytic, cholinesterase, phospholipase and ﬁbri-
nolytic activities (Zlotkin, 1978; Possani, 1984). However, toxic
effects are mainly caused by a class of proteins called neurotoxins,
which act on various ion channels (Possani et al., 1977, 1999;
Wagner et al., 2003; Vasconcellos et al., 2005; Kahn et al., 2009).
The scorpion venoms of the same genus have similar components;
the toxins have high homology in their amino acid sequences and
structural features and also are antigenically very similar (Possani
et al., 1992, 1999; Batista et al., 2007; Gao et al., 2008; Borges
et al., 2008, 2010; Chen and Khung, 2012a, 2012b).
The recommended treatment in a scorpion sting event is the
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have two sera treatments for accidents with scorpions: anti-
scorpion (produced with the whole venom of T. serrulatus) and
anti-arachnid (produced with a mixture of venoms of spiders and
scorpion T. serrulatus), which are used in all cases of accidents
involving scorpions, regardless of the species (Ministry of Health
(2011)). The T. serrulatus venom is utilized solely in serum pro-
duction because of its medical importance and thewell-established
cross-reactivity between venoms of Tityus genus (Nishikawa et al.,
1994; D'Suze et al., 2007). However, no cross-neutralization study
has been done, with the exception of T. bahiensis venom. It was
demonstrated that this venom is well neutralized by serum anti-
T. serrulatus (Nishikawa et al., 1994).
Evaluation of the neutralizing ability of individual antivenoms is
a necessary qualiﬁcation step before they can be release for ther-
apeutic usage. In Brazil, an ED50 0.5 mg of T. serrulatus venom per
milliliter of serum is the required minimum potency (Maria et al.,
2005).
In toxinology ﬁeld, synthetic peptides that mimic epitopes have
been used as antigen for serum therapy and vaccines development
(Calderon-Aranda et al., 1995; Alvarenga et al., 2002; Machado
Avila et al., 2004; Felicori et al., 2009; Duarte et al., 2010; Dias-
Lopes et al., 2010), and to evaluate antivemons neutralizing po-
tency (Maria et al., 2005; Ramada et al., 2013). The spot synthesis is
an easy technique for the positionally addressable, parallel chem-
ical synthesis on a membrane support (Frank, 1992; Molina et al.,
1996) and subsequently was applied to identiﬁcation of peptides
and amino acids from the antibody paratope that contribute to
antigen binding (Laune et al., 2002). Through this technique,
several studies have deﬁned synthetic peptides able to neutralize
venom's toxic effects (Alvarenga et al., 2005; Felicori et al., 2006;
Duarte et al., 2010; Dias-Lopes et al., 2010).
Therefore, the aim of this work is the molecular and immuno-
logical study of the venom T. fasciolatus and identiﬁcation of
important structural regions to produce neutralizing antibodies.
For this purpose, we used primers of known toxins from
T. serrulatus to verify and obtain homologous sequences present in
the venom of T. fasciolatus. We have ﬁnd amino acid sequences of
three T. fasciolatus toxins and synthesized a set of overlapping
peptides bounded to cellulose membrane (spot-synthesis tech-
nique) to identify linear epitopes recognized by antibodies obtained
by immunization of sheep with T. fasciolatus crude venom.
2. Materials and methods
2.1. Animals, venoms and antivenoms
Scorpion venom was extracted from T. fasciolatus, kindly pro-
vided by the Centre of Zoonosis Control (Ituiutaba, MG, Brazil), and
dissolved in ultra-pure water.
Fifty-six male Swiss CF1 mice, weighing 18e22 g, were obtained
from the Centro de Bioterismo of the Institute of Biological Sciences
(CEBIO), UFMG (Belo Horizonte, Brazil) and receivedwater and food
under controlled environmental conditions.
We used two healthy sheep, two years old and weighing 40 kg,
without deﬁned breed obtained from the Veterinary School of the
Federal University of Minas Gerais (UFMG) (Belo Horizonte, Brazil).
The sheep were inoculated subcutaneously with 500 mg venom of
T. fasciolatus or T. serrulatus in Freund's complete adjuvant (day 1),
respectively. Ten subsequent immunizations were made with a
week interval between them with the same dose in Freund's
incomplete adjuvant. Seven days after the last inoculation were
performed blood sampling by jugular vein puncture with vacuum
system for collection. The blood was centrifuged and the obtained
serum was kept at 20 C.The managements and procedures involving animal experi-
ments were approved by Ethics Committee on Animal Experiments
of UFMG (CETEA) (protocol number 131/2006).
2.2. ELISA and western blotting analyses
Falcon ﬂexible microtitration plates purchased from Becton
Dickinson Labware Europe (Becton Dickinson France S. A.) were
coated overnight at 4 C with 100 ml of 5 mg/mL solution of
T. fasciolatus venom or T. serrulatus venom in 20 mM sodium bi-
carbonate buffer, pH 9,6. Serum anti-T. serrulatus and anti-
T. fasciolatus venom, diluted 1:100, were tested for recognition
against whole venom of two scorpions. The assays were performed
as described previously by Chavez-Olortegui et al. (1991). Absor-
bance values were determined at 492 nmwith a Titertek Multiscan
spectrophotometer. All measurements were made in duplicate.
The T. fasciolatus venom and T. serrulatus venom were solubi-
lized in reducing sample buffer and run on 15% SDS-PAGE
(Laemmli, 1970). Two gels were made, after electrophoresis, one
was stainedwith Coomassie Blue G-250 for identiﬁcation of protein
bands and other was transferred to a 0.45 mm nitrocellulose
membrane as described by Alvarenga et al. (2002). This was sub-
sequently used to verify the pattern of recognition of venoms
against anti-T. serrulatus and anti-T. fasciolatus sera. The assays were
performed as described previously by Guatimosin et al. (1999) and
sera were used at a dilution of 1:200.
2.3. In vitro neutralization assay
The neutralization assay was adapted fromMendes et al. (2008).
We used 56 male CF1 Swiss mice, weighing between 18 and 22 g. A
vial of serum produced by FUNED 5 mg is capable of neutralizing
the venom of the scorpion T. serrulatus (1 mg/mL). The dose of the
venom of T. fasciolatus used, 134.2 mg/mouse (minimum mortal
dose that kills 100% eMMD determined in the study of LD50) was
incubated for one hour at 37 C with 200 ml or 100 ml of scorpion
anti-serum and PBS. The dose of the venom of T. serrulatus used,
52.65 mg/mouse (equivalent to the study of MMD determined
LD50) was incubated for one hour at 37 C with 200 ml or 100 ml of
scorpion anti-serum and PBS. The groups were assembled accord-
ing to Table 2. Were used four animals per group and inoculations
were done subcutaneously. The count of survivors was realized
48 h after the challenge.
2.4. Molecular identiﬁcation of toxins from T. fasciolatus venom
2.4.1. Extraction and puriﬁcation of RNA
All procedures were performed at 4 C, using water treated with
diethyl pyrocarbonate (DEPC). The venom gland (telson) of
T. fasciolatus was extracted and macerated using a mortar and
pestle on dry ice until it formed a powder. This was resuspended in
200 ml of denaturation solution (4 M guanidinium thiocyanate,
0.1 M Tris HCl pH 7.0, 0.5 M sarcosyl and 1% b-mercaptoethanol)
and transferred to a microtube. The homogenate was added 20 ml of
2 M sodium acetate pH 4.0 (1/10 volume), 200 ml of phenol acid (1
volume) and 40 ml of chloroform: isoamyl alcohol (24:1) (2/10
volume) and mixed by vigorous shaking and the tube containing
the mixture was kept on ice for 15 min. Then, the solution was
centrifuged at 10,000 g for 20 min at 4 C. The aqueous phase was
transferred to a microtube, and was added one volume of iso-
propanol and kept at 20 C for approximately 15 h. Then, the
sample was centrifuged at 13,200 g for 30 min at 4 C and the su-
pernatant discarded. The pellet was resuspended in 50 mL of
denaturation solution were added to 125 ml of ethanol solution 95%
(2.5 volumes). The samplewas homogenized and kept at20 C for
Table 1
Sequence of primers used to perform the RT-PCR.
Sequence of primers Gene Access number (gen bank)
First RT-PCR Ts4 AF039599.1
Foward e 50 CTC GAG GGT AGA GAA GGT TAT CCA G
Reverso e 50 CTC GAG GCC ACA TTT ATT CGT TTC ACT AGT CC
Second RT-PCR
Foward e 50 CAT ATG GCT TAT TGC TGA TCG ACA TTG TCG TAG G 30
Reverso e 50 CAT ATG CAG TTC ATT TGT AAA GGA ATT TCA GTG ATG 30
First RT-PCR Ts3 S69808.1
Foward e 50 GTC GAC AAG AAA GAC GGA TAC CCG
Reverso e GTC GAC GGA TTT GCA TTT TCC GTT GG 30
Second RT-PCR
Foward e 50 CAT ATG GCT TAT TGA CCG CGG GCA CGG AGG GC 30
Reverso e 50 CAT ATG GGA GGC TGG TTT ACT TCT TAC C 30
First RT-PCR Ts1 X66256.1
Foward e AAG CTT AAA GAA GGT TAT CTC ATG
Reverso e AAG CTT ACA TTT GTT CGT CGC TCT ATC C 30
Second RT-PCR
Foward e 50 CAT ATG GCT GAT CGG CAT TGT CGT AGA ATG 30
Reverso e 50 CAT ATG GCG AAA CAA ATT TAT TTT TTG CC 30
Table 2
In vivo neutralization assay.
Groups Description Survival
G1 134.2 mg T. fasciolatus venom þ 100 ml anti-T. serrulatus serum 2/4
G1a 134.2 mg T. fasciolatus venom þ 100 ml PBS 0/4
G2 134.2 mg T. fasciolatus venom þ 200 ml anti-T. serrulatus serum 4/4
G2a 134.2 mg T. fasciolatus venom þ 200 ml PBS 0/4
G3 52.65 mg T. serrulatus venom þ 100 ml anti-T. serrulatus serum 4/4
G3a 52.65 mg T. serrulatus venom þ 100 ml PBS 0/4
G4 134.2 mg T. fasciolatus venom þ 100 ml anti-T. fasciolatus serum 4/4
G4a 134.2 mg T. fasciolatus venom þ 100 ml PBS 0/4
G5 100 ml anti-T. serrulatus serum 4/4
G5a 200 ml anti-T. serrulatus serum 4/4
Male Swiss CF1 mice (4 animals per group) were inoculated sub cutaneously. The count of survivors was realized 48 h after the challenge.
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30 min at 4 C. The supernatant was discarded. The pellet was
washed with 70% ethyl alcohol with care and then left in contact
with air to dry; the pellet was resuspended in deionized water.2.4.2. cDNA syntheses and cloning of homologous toxins
The synthesis of complementary DNA (cDNA) was made using
RNA puriﬁed from the venom gland of T. fasciolatus and RT-PCR Kit
(QuickTM Access RT-PCR System e Promega Corporation). To
perform the RT-PCR, primers described the toxins (mature protein)
from T. serrulatus were used (Table 1). The RT-PCR product was
analyzed on 1% agarose gel and the band of interest as was puriﬁed
from the gel using the kit “Wizard SV Gel and PCR Clean-up System”
(Promega). After puriﬁcation, the ampliconwas cloned into pCR2.1-
TOPO vector according to manufacturer's recommendations (Invi-
trogen). The ligation product was transformed into E. coli XL1 Blue.
Large-scale plasmid isolations from bacteria were carried out ac-
cording to the alkaline lysis SDS method described by Sambrook
et al. (1989). Vectors containing the sequence of interest were
selected by PCR and were further analyzed by DNA sequencing.2.4.3. Sequencing and computational analyzes of homologous
toxins
The sequencing of plasmids quantiﬁed was performed on the
MegaBACE DNA sequencer in the Laboratory of Molecular Evolution
and Biodiversity at UFMG. The sequencing reaction was performed
using the kit DYEnamic ET Dye Terminator Cycle Sequencing
(Amersham Biosciences). The nucleotide sequences were analyzed
with the program “Basic Local Alignment Search Tool Program foramino acids” e Blast e GenBank (Altschul and Lipman, 1990 e
www.ncbi.nlm.nih.gov) and the program DNAstar Lasergene 6
(Sentinel M®).
Since the primers used for obtainment the nucleotides sequence
of toxins from T. fasciolatus were constructed from the nucleotide
sequence of the toxins of T. serrulatus, the regions N-terminal and
C-terminal (the region annealing of the primers) are not the true
sequences of the toxins of T. fasciolatus. To obtain this region, we
built new primers using the nucleotide sequence of the mRNA
(messenger RNA) of toxins Ts1, Ts3 and Ts4 from T. serrulatus
already described in the literature, but this time used the signal
peptide and 30 untranslated regions, to give entire mature protein
sequence.
After deﬁning the new primers was performed again RT-PCR to
obtain the new sequence of toxins from T. fasciolatus, puriﬁcation of
cDNA amplicon, binding of the cloning vector, plasmid puriﬁcation
and sequencing and sequence analysis as described previously
(Sambrook et al., 1989).2.5. Mapping of linear B-cell epitopes
For the epitope mapping of the new toxins described in this
work, ﬁfty-ﬁve overlapping pentadecapeptides frameshifted by
three residues covering the aminoacid sequences of the three new
toxins of T. fasciolatus were synthesized on cellulose membranes
according to the protocol previously described by Laune et al.
(2002). Membranes were obtained from Intavis (Koln, Germany);
Fmoc amino acids and activators (Oxyme pure and N,N0-Diisopro-
pylcarbodiimide) were acquired from Novabiochem. A ResPep SL/
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peptide synthesis. All peptides were acetylated at their N-terminus.
After the peptide sequences had been assembled, the side-chain
protecting groups were removed by triﬂuoroacetic acid treatment
(Frank, 1992).
After an overnight saturation step with blocking buffer (Roche,
France), the set of membrane bound peptides was probed by in-
cubation with 25 mg/mL of IgG from immunized sheep with
T. fasciolatus and T. serrulatus during 90 min. The immunoassay was
performed as described by Dias-Lopes et al. (2010). The alkaline-
phosphatase conjugated anti-sheep antibody (Sigma) was diluted
1:3000. The revelation was performed with a phosphatase sub-
strate [5-bromo-4-chloro-3-indolyl phosphate (BCIP) and 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
(Sigma).2.6. Homology models
Three-dimensional models of Tf1 and Tf3 were constructed
using the SWISS-MODEL structure homology-modeling server
(Kiefer et al., 2009; Kopp and Schwede, 2006; Arnold et al., 2006;
Schwede et al., 2003). The structural model of Tf4a was con-
structed using the solution structure of Ts 1 (PDB ID 1B7D) as a
template and swiss-pdbviewer package (Guex and Peitsch, 1997)
for model generation. The epitopes mapped to the three toxins
were localized in their respective three-dimensional model and
visualized using DeepView/Swiss-PdbViewer package.3. Results
3.1. General characterization of T. fasciolatus scorpion venom
The lethal potency of T. fasciolatus crude venom (LD50) deter-
mined in this study by the subcutaneous route was of 59.65 mg per
mouse or 59.65 mg/20 g (2.984 mg/kg) with a range between
52.72 mg/20 g and 67.5 mg/20 g. Injected mice displayed typical
symptoms of intoxication such as excitability, agitation, salivation,
eye secretions, sweating, convulsions and paralysis of legs. The
symptoms lasted for 30e120 min before death.Fig. 1. Cross-reactivity between the venoms of T. fasciolatus and T. serrulatus. ELISA plates w
given are the means of duplicates. The absorbance of the samples was determined at 49
T. serrulatus venom.T. serrulatus and T. fasciolatus venoms are very similar in poly-
acrylamide gels, both show strong bands of 6e10 kDa, 25e50 kDa
and several bands above 60 kDa (data not shown). The difference is
that the venom of T. serrulatus presents bands in the range of
15e20 kDa and the bands in the range of 25e50 are stronger in the
venom of T. fasciolatus.
The cross-reactivity between venoms from Tityus serrulatus and
Tityus fasciolatus were evaluated by Western blotting and ELISA.
Both sera recognized bands of low weight (7e10 kDa), in the range
of 30e40 kDa and bands over 60 kDa with less intensity (data not
shown) and reacted strongly against venom antigens coated on the
ELISA plates (Fig. 1). These observations suggest the presence of
antigenic identities or common epitopes across the two scorpion
genera studied.
The anti-T. fasciolatus and anti-T. serrulatus sera neutralizing
potency analysis against the lethal activity of these venoms is
shown in Table 2. In this study, it was observed that each speciﬁc
serum neutralizes the lethal effects of their own venom toxins.
However, anti-T. serrulatus serum was not able to neutralize efﬁ-
ciently the lethal effects of T. fasciolatus venom, requiring a higher
dose of serum to achieve the same result with the venom of
T. serrulatus.3.2. Molecular identiﬁcation of three toxins of T. fasciolatus venom
The use of primers constructed from the nucleotide sequence of
toxins Ts1, Ts3 and Ts4 from the venom of T. serrulatuswas effective
in obtaining the nucleotide sequence homologous toxins present in
the venom of T. fasciolatus (Fig. 2). The DNA sequences were called
as Tf1, homologous the Ts1 (94% identity); Tf3, homologous the Ts3
(89% identity) and Tf4a, homologous the Ts6 (78% identity) and Tf4,
the only toxin of T. fasciolatus already described (Wagner et al.,
2003). The toxin Tf1 has 60% similarity with other beta-type
toxins of scorpions of the genus Tityus, the Tf3 has 42% similarity
to other alpha-type of scorpions of the same gender and Tf4a has
63% similarity with the non-toxic proteins (Fig. 4). The Tf4a shows
only one amino acid difference compared with the one already
described the Tf4 toxin of T. fasciolatus. At position 26, there is a
lysine (K) where it would be a threonine (T).ere coated with 5 mg/mL solution of each venom. Sera were diluted at 1:100 and values
2 nm. The abbreviation Tf corresponds to T. fasciolatus venom and Ts corresponds to
Fig. 2. Alignment of amino acids sequences of new toxins from Tityus fasciolatus. (A) Alignment of the amino acid sequence of the T. fasciolatus toxin (Tf1) with other beta-type
toxins from scorpions of the genus Tityus. (B) Alignment of the amino acid sequence of the T. fasciolatus toxin (Tf3) with other toxins from scorpions. (C) Alignment of amino
acid sequence of the T. fasciolatus toxin (Tf4a) with other scorpion toxins of the genus Tityus. Basic amino acids are pink; acid amino acids are blue; small amino acids, aromatic and
hydrophobic amino acids are red and amino and hydroxyl is green. The cysteines are displayed in yellow. Amino acids in all homologous sequences are indicated by (*). Sequences
obtained from Swiss-Prot Database. Species and the access code of toxins are: Tco_gamma (Tityus costatus-Q5G8B8), Ts1 (Tityus serrulatus-P15226) Tst_gamma (Tityus stigmurus-
P56612) Tb_gamma (Tityus bahiensis-P56611) and TZ1 (Tityus zulianus-Q2NME3), TbTx5 (Tityus bahiensis-POC5K8), Ts3 (Tityus serrulatus-P01496), Ts5 (Tityus serrulatus-P46115)
CsE5 (Centruroides sculpturatus-P46066) Kurtoxin (Parabuthus transvalicus-P58910), Tf4 (Tityus fasciolatus-P83435) TbIT_1 (Tityus bahiensis-P60275) TcoNTxP1 (Tityus costatus-
Q5G8A8), Ts6 (Tityus serrulatus-P45669) TsNTxP (Tityus serrulatus-077463). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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Spot technique was used to deﬁne the epitopes recognized by
both sera used in this work and found some differences. In the case
of Tf1 toxin, both sera recognized two epitopes. The ﬁrst is common
to both sera and comprises amino acid residues 1e15, but the
second epitope is a little different. The second epitope recognized
by the T. fasciolatus anti-venom serum (Tf serum) comprises amino
acid residues 13e27 while T. serrulatus anti-venom serum (Ts
serum) comprises amino acid residues 22e36 (Fig. 3A).In the case of Tf3, the Ts serum recognizes only one epitope (N-
Terminal/residues 1e15). Since the Tf serum recognizes two epit-
opos: one at the N-terminal region (7e24) and one in the C-ter-
minal region (40e57) (Fig. 3B).
There is a difference in sera pattern recognition of the toxin Tf4a,
the Ts serum recognizes more epitopes that the Tf serum. The Ts
serumrecognizes threeepitopes:oneat theN-terminal region (1e18),
one central (25e45) andone in theC-terminal region (49e60). AndTf
serum recognizes two epitopes: one at the N-terminal region (1e18)
and one in the C-terminal region (37e57) (Fig. 3C).
Fig. 3. Difference in reactivity of sera anti-T. serrulatus and anti-T. fasciolatus front of the set of peptides of toxins identiﬁed in the venom of the scorpion Tityus fasciolatus. Fifty-ﬁve
overlapping pentadecapeptides frameshifted by three residues covering the three toxins of Tityus fasciolatus described in this work were synthesized on cellulose membranes. A.
Peptides set of Tf1 toxin. B. Peptides set of Tf3 toxin. C. Peptides set of Tf4a toxin. The binding of sheep IgG anti-venoms (25 mg/mL) to cellulose-bound peptides was detected by an
alkalineephosphatase coupled anti-sheep antibody (diluted 1:3000). Tf corresponds to IgG anti-T. fasciolatus and Ts corresponds to IgG anti-T. serrulatus.
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(PDB Accession code: 1b7dA) as amodel for Tf1 and Tf4a. The toxin-
CsE V (PDB Accession code: 1nraA) as a model for Tf3 and SWISS-
MODEL for the model generation. The linear epitopes recognized
by the three toxins serum venom T. fasciolatuswere located in their
three-dimensional models and visualized using the swiss-
pdbviewer package. Several residues important for toxin activityand its binding to its active site, described in the literature, were
found as part of the epitopes mapped in this work (Fig. 4).
4. Discussion
In Brazil, the scorpions of medical importance belong to the
genus Tityus. The accidents involving the T. serrulatus species are
Fig. 4. Surface functional and residues important for activity of the toxin and its ionic channel binding. Tf1: ﬁrst epitope in red and second epitope marked in green. Tf3: ﬁrst
epitope in magenta and second epitope marked in blue. Tf4a: ﬁrst epitope in red and second epitope marked in blue. Amino acid residues important for binding, function and
activity of scorpion toxins that have been kept in toxins of T. fasciolatus were identiﬁed in the 3D structure of the toxins studied. The Tf4a was analyzed as such as beta and alpha
toxin. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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study of others species of this genus has been relegated (Szilagyi-
Zecchin et al., 2012). For this reason the available sera to treat
poisoned patients are prepared only with T. serrulatus venom.
However, this serum ability to neutralize toxic effects of the venom
of other species of the genus Tityus was not demonstrated.
The T. fasciolatus is an endemic species found in Brazilian central
region and a few is known about its venom (Wagner et al., 2003;
Pinto et al., 2010). Therefore, in this work, we decided to study
some immunological and molecular characteristics of this venom,
verify that the T. serrulatus anti-venom serum is able to neutralize
its toxic effects and evaluate which linear epitopes may be involved
in this process.
We found that the T. fasciolatus can be classiﬁed as very toxic
venom according to a study by Nishikawa et al. (1994) and there-
fore may be considered of medical importance. According to the
parameters studied, the venoms of T. fasciolatus (Tf) and
T. serrulatus (Ts) are molecular and immunogically similar. How-
ever, the linear epitopes pattern recognition by the two sera tested
was slightly different. In addition, to obtain a complete neutrali-
zation of Tf venom, it was necessary to use a higher dose of anti-
T. serrulatus serum, when compared with anti-T. fasciolatus serum.
That indicates some differences between two sera.
Borges et al. (2008), studied seven Tityus scorpion species found
in Venezuela, showed that the venoms have similar components.
However, they have found that there were a species-speciﬁc elec-
trophoretic proﬁles and although the venoms have immunologic
cross-reactivity, the commercial serum produced with Tityus dis-
crepans venom, was not able to neutralize the toxic effects of othervenoms with efﬁciency (Borges et al., 2006, 2008, 2010).
In this context, new approach in serum production becomes
necessary. Mendes et al. (2013) produced a serum with a recom-
binant chimeric protein multi-epitopes and an effective anti-
elapidic serum (coral snake) has been produced using whole
venom of Micrurus frontalis and a mixture of synthetic peptides
mimicking the neutralizing epitopes of Micrurus coralinus toxins
(Castro et al., 2015). Therefore, mapping of species-speciﬁc anti-
genic epitopes could lead to the development of a more effective
serum for treatment in envenomation by various scorpion Tityus
species found in Brazil or even in South America.Ethical statement
The authors declare that the work “General characterization of
Tityus fasciolatus scorpion venom. Molecular identiﬁcation of
toxins and localization of linear B-cell epitopes” is an original
work of the group, which has not been previously published else-
where, reﬂects on own research and analysis of the authors was
made true and complete way. The contributions of co-authors and
co-researchers were properly credited.
We all procedures were performed in compliance with relevant
laws and institutional guidelines and that the appropriate institu-
tional committee(s) has approved them.Conﬂict of interest
The authors declare that they have no conﬂicts of interest.
T.M. Mendes et al. / Toxicon 99 (2015) 109e117116Acknowledgments
This research was supported by Coordenaç~ao de Aperfeiçoa-
mento de Pessoal de Nível Superior, Brazil e CAPES (Toxinologia N
23038000825/2011-63), Fundaç~ao de Amparo a Pesquisa do Estado
de Minas Gerais, Brazil (FAPEMIG) and by funds of the INCTTOX
Program of Conselho Nacional de Desenvolvimento Cientíﬁco e
Tecnologico, Brazil (CNPq) (573790/2008-6).References
Altschul, S.F., Lipman, D.J., 1990. Protein database searches for multiple alignments.
Proc. Natl. Acad. Sci. U. S. A. 87 (14), 5509e5513.
Alvarenga, L.M., Diniz, C.R., Granier, C., Chavez-Olortegui, C., 2002. Induction of
neutralizing antibodies against Tityus serrulatus scorpion toxins by immuniza-
tion with a mixture of deﬁned synthetic epitopes. Toxicon 40 (1), 89e95.
Alvarenga, L.M., Machado de Avila, R.A., Amim, P.R., Martins, M.S., Kalapothakis, E.,
de Lima, M.E., Snatos, R.G., Granier, C., Chavez-Olortegui, C., 2005. Molecular
characterization of a neutralizing murine monoclonal antibody against Tityus
serrulatus scorpion venom. Toxicon 46 (6), 664e671.
Arnold, K., Bordoli, L., Kopp, J., Schwede, T., 2006. The Swiss-model workspace: a
web-based environment for protein structure homology modelling. Bioinfor-
matics 22, 195e201.
Batista, C.V., Roman-Gonzalez, S.A., Salas-Castillo, S.P., Zamudio, F.Z., Gomez-
Lagunas, F., Possani, L.D., 2007. Proteomic analysis of the venom from the
scorpion Tityus stigmurus: biochemical and physiological comparison with
other Tityus species. Comp. Biochem. Physiol. C 146 (1e2), 147e157.
Borges, A., Garcia, C.C., Lugo, E., Alfonzo, M.J., Jowers, M.J., Op den Camp, H.J., 2006.
Diversity of long-chain toxins in Tityus zulianus and Tityus discrepans venoms
(Scorpiones, Buthidae): molecular, immunological, and mass spectral analyses.
Comp. Biochem. Physiol. C Toxicol. Pharmacol. 142 (3e4), 240e252.
Borges, A., De Souza, L., Espinoza, J., Melo, M.M., Santos, R.G., Kalapothakis, E.,
Valadares, D., Chavez-Olortegui, C., 2008. Characterization of Tityus scorpion
venoms using synaptosome binding assays and reactivity towards Venezuelan
and Brazilian Antivenoms. Toxicon 51 (1), 66e79.
Borges, A., Bermingham, E., Herrera, N., Alfonzo, M.J., Sanjur, O.I., 2010. Molecular
systematic of the neotropical scorpion genus Tityus (Buthidae) the historical
biogeography and venom antigenic diversity of toxic Venezuelan species.
Toxicon 55 (2e3), 436e454.
Calderon-Aranda, E.S., Olamendi-Portugal, T., Possani, L.D., 1995. The use of syn-
thetic peptides can be a misleading approach to generate vaccines against
scorpion toxins. Vaccine 13 (13), 1198e1206.
Castro, K.L., Duarte, C.G., Ramos, H.R., Machado de Avila, R.A., Schneider, F.S.,
Oliveira, D., Freitas, C.F., Kalapothakis, E., Ho, P.L., Chavez-Olortegui, C., 2015.
Identiﬁcation and characterization of B-cell epitopes of 3FTx and PLA2 toxins
from Micrurus corallinus snake venom. Toxicon 93, 51e60.
Chavez-Olortegui, C., Amaral, D.A., Rochat, H., Diniz, C., Granier, C., 1991. In vivo
protection against scorpion toxins by liposomal immunization. Vaccine 9 (12),
907e910.
Chen, R., Chung, S.H., 2012a. Binding modes and functional surface of anti-
mammalian scorpion a-toxins to sodium channels. Biochemistry 51 (39),
7775e7782.
Chen, R., Chung, S.H., 2012b. Conserved functional surface of antimammalian
scorpion b-toxins. J. Phys. Chem. B 116 (16), 4796e4800.
Dias-Lopes, C., Guimar~aes, G., Felicori, L., Fernandes, P., Emery, L., Kalapothakis, E.,
Nguyen, C., Molina, F., Granier, C., Chavez-Olortegui, C., 2010. A protective im-
mune response against lethal, dermonecrotic and hemorrhagic effects of Lox-
osceles intermedia venom eliceted by a 27-residue peptide. Toxicon 55 (2e3),
481e487.
Duarte, C.G., Alvarenga, L.M., Dias-Lopes, C., Machado-de-Avila, R.A., Nguyen, C.,
Molina, F., Granier, C., Chavez-Olortegui, C., 2010. In vivo protection against
Tityus serrulatus scorpion venom by antibodies raised against a discontinuous
synthetic epitope. Vaccine 28 (5), 1168e1176.
D'Suze, G., Moncada, S., Gonzalez, C., Sevcik, C., Alagon, A., 2007. Antigenic cross-
reactivity between sixteen venoms from scorpions belonging to six genera.
Clin. Toxicol. (Phila) 45 (2), 158e163.
Felicori, L., Fernandes, P.B., Giusta, M.S., Duarte, C.G., Kalapothakis, E., Nguyen, C.,
Molina, F., Granier, C., Chavez-Olortegui, C., 2006. An in vivo protection response
against toxic effects of the dermonecrotic protein from Loxosceles intermedia
spider venom elicited by synthetic epitopes. Vaccine 27 (31), 4201e4208.
Felicori, L., Araujo, S.C., de Avila, R.A., Sanchez, E.F., Granier, C., Kalapothakis, E.,
Chavez-Olortegui, C., 2009. Functional characterization and epitope analysis os
a recombinant dermonecrotic protein from Loxosceles intermedia spider. Tox-
icon 48 (5), 509e519.
Frank, R., 1992. Spot synthesis: an easy technique for the positionally addressable,
parallel chemical synthesis on a membrane support. Tetrahedron 48,
9217e9232.
Gao, R., Zhang, Y., Gopalakrishnakone, P., 2008. Puriﬁcation and N-terminal
sequence of a serine proteinase-like protein (BMK-CBP) from the venom of the
Chinese scorpion (Buthus martensii Karsch). Toxicon 52 (2), 348e353.
Guex, N., Peitsch, M.C., 1997. SWISS-MODEL and the Swiss-PdbViewer: anenvironment for comparative protein modeling. Electrophoresis 18 (15),
2714e2723.
Guatimosin, S.C., Prado, V.F., Diniz, C.R., Chavez-Olortegui, C., Kalapothakis, E., 1999.
Molecular cloning and genomic analysis of TsNTxp: an immunogenic protein
from Tityus serrulatus scorpion venom. Toxicon 37 (3), 507e517.
Kahn, R., Karbat, I., Ilan, N., Coheb, L., Sokolov, S., Catterall, W.A., Gordon, D.,
Gurevitz, M., 2009. Molecular requirements for recognition of brain voltage-
gated sodium channels by scorpion a-toxins. J. Biol. Chem. 284 (31),
20684e20691.
Kiefer, F., Arnold, K., Künzli, M., Bordoli, L., Schwede, T., 2009. The SWISS-MODEL
repository and associated resources. Nucleic Acids Res. 37, D387eD392.
Kopp, J., Schwede, T., 2006. The SWISS-MODEL Repository: new features and
functionalities. Nucleic Acids Res. 34, D315eD318.
Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head
of bacteriophage T4. Nature 227 (5259), 680e685.
Laune, L., Molina, F., Ferrieres, G., Vllard, S., Bes, C., Rieunier, F., Chardes, T.,
Granier, C., 2002. Application of the spot method to the identiﬁcation of pep-
tides and amino acids from the antibodie paratope that contribute to antigen
binding. J. Immunol. Methods 267 (1), 53e70.
Lira-da-Silva, R.M., Amorim, A.M., Brazil, T.K., 2000. Poisonous sting by Tityus stig-
murus (Sorpiones; Buthidae) in the state of Bahia, Brazil. Rev. Soc. Bras. Med.
Trop. 33 (3), 239e245.
Lourenço, W.R., 1995. Les scorpions (Chelicerata, Scorpiones) de l'Equateur avec
quelques considerations sur la biogeographie et la diversite des especes. Rev.
Suisse Zool. 102 (1), 61e88.
Lourenço, W.R., Eickstedt, V. R. D. Von, 2003. Escorpi~oes de Importa^ncia Medica. In:
Cardoso, J.L.C., França, F.O.S., Fan, H.W., Malaque, C.M.S., Haddad Jr., V. (Eds.),
Animais Peçonhentos No Brasil. Biologia, Clínica Eterape^utica Dos Acidentes.
Editora Sarvier, S~ao Paulo, pp. 182e197.
Maria, W.S., Velarde, D.T., Alvarenga, L.M., Nquyen, C., Villard, S., Granier, C., Chavez-
Olortegui, C., 2005. Localization of epitopes in the toxins of Tityus serrulatus
scorpions and neutralizing potential of therapeutic antivenoms. Toxicon 46 (2),
210e217.
Machado de Avila, R.A., Alvarenga, L.M., Tavares, C.A., Molina, F., Granier, C., Chavez-
Olortegui, C., 2004. Molecular characterization of protective antibodies raised in
mice by Tityus serrulatus scorpion venom toxins conjugated to bovine serum
albumin. Toxicon 44 (3), 233e241.
Mendes, T.M., Dias, F., Horta, C.C.R., Pena, I.F., Arantes, E.C., Kalapothakis, E., 2008.
Effective Tityus serrulatus anti-venom produced using the Ts1 component.
Toxicon 52 (7), 787e793.
Mendes, T.M., Oliveira, O., Figueiredo, L.F., Machado-de-Avila, R.A., Duarte, C.G.,
Dias-Lopes, C., Guimar~aes, G., Felicoli, L., Minozzo, J.C., Chavez-Olortegui, C.,
2013. Generation and characterization of a recombinant chimeric protein
(rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles
intermedia spider venom. Vaccine 31 (25), 2749e2755.
Ministerio da Saúde, 2011. Escorpionismo. In: Ccomed/Asplan/Fns (Ed.), Manual de
diagnostico e tratamento de acidentes por animais peçonhentos. Fundaç~ao
Nacional de Saúde, Brasília, pp. 39e47.
Molina, F., Laune, D., Gougat, C., Pau, B., Granier, C., 1996. Improved performances of
spot multiple peptide synthesis. Pept. Res. 9 (3), 151e155.
Nishikawa, A.K., Caricati, C.P., Lima, M.L., Dos Santos, M.C., Kipnis, T.L.,
Eickstedt, V.R., Knysak, I., Da Silva, M.H., Higashi, H.G., Da Silva, W.D., 1994.
Antigenic cross-reactivity among the venoms from several species od Brazilian
scorpions. Toxicon 32 (8), 989e998.
Pardal, P.P.O., Castro, L.C., Jennings, E., Pardal, J.S., Monteiro, M.R., 2003. Epidemi-
ological and clinical aspects of scorpion envenomation in the region of
Santarem, Para, Brazil. Rev. Soc. Med. Trop. 36 (3), 349e353.
Pinto, M.C.L., Borboleta, L.R., Melo, M.B., Labarrere, C.R., Melo, M.M., 2010. Tityus
fasciolatus envenomation induced cardio-respiratory alterations in rats. Toxicon
55 (6), 1132e1137.
Possani, L.D., Alagon, A.C., Fletcher, P.L., Erickson, B.W., 1977. Puriﬁcation and
properties of mammalian toxins from the venom of Brazilian scorpion Tityus
serrulatus Lutz and Mello. Arch. Biochem. Biophys. 180 (2), 394e403.
Possani, L.D., 1984. Structure of scorpion toxins. In: Tu, A.T. (Ed.), Handbool of
Natural Toxins, Structure of Scorpion Toxins, vol. 2. Marcel Dekker, INC., New
York, pp. 513e550.
Possani, L.D., Fletcher, P.L., Fletcher, M.D., Rode, G.S., Mochca-Morales, J., Lucas, S.,
Coronas, F.V., Alagon, A.C., Martin, B.M., 1992. Structural and functional char-
acteristics of toxins puriﬁed from venom of the Brazilian scorpion Tityus ser-
rulatus Lutz and Mello. Memorias do Inst. Butantan 54 (2), 35e52.
Possani, L.D., Becerril, B., Delepierre, M., Tytgat, J., 1999. Scorpion toxins speciﬁc for
Naþ-channels. Eur. J. Biochem. 264 (2), 287e300.
Ramada, J.S., Becker-Finco, A., Minozzo, J.C., Felicoli, L.F., Machado de Avila, R.A.,
Molina, F., Nguyen, C., de Moura, J., Chavez-Olortegui, C., Alvarenga, L.M., 2013.
Synthetic peptides for in vitro evaluation of the neutralizing potency of Lox-
osceles antivenoms. Toxicon 73, 47e55.
Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning: a Laboratory
Manual, vol. 1e3. Col Spring Harbor Laboratory Press, New York.
Schwede, T., Kopp, J., Guex, N., Peitsch, M.C., 2003. SWISS-MODEL: an automated
protein homology-modeling server. Nucleic Acids Res. 31, 3381e3385.
Szilagyi-Zecchin, V.J., Fernandes, A.L., Castagna, C.L., Voltolini, J.C., 2012. Abundance
of scorpions Tityus serrulatus and Tityus bahiensis associated with climate in
urban area (scorpiones, buthidae). Indian Soc. Arachnol. 1 (2), 15e23.
Vasconcelos, F., Lanchote, V.L., Bendhack, L.M., Giglio, J.R., Sampaio, S.V.,
Arantes, E.C., 2005. Effects of voltage-gated Naþ channel toxins from Tityus
T.M. Mendes et al. / Toxicon 99 (2015) 109e117 117serrulatus venom on rat arterial blood pressure and plasma catecholamines.
Comp. Biochem. Physiol. C Toxicol. Pharmacol. 141 (1), 85e92.
Wagner, S., Castro, M.S., Barbosa, J.A., Fontes, W., Schawartz, E.N., Sebben, A.,
Rodrigues Pires Jr., O., Sousa, M.V., Schwartz, C.A., 2003. Puriﬁcation andprimary structure determination of Tf4, the ﬁrst bioactive peptide isolated from
the venom of the Brazilian scorpion Tityus fasciolatus. Toxicon 41 (7), 737e745.
Zlotkin, E., 1978. Chemistry and pharmacology of buthinae scorpion venoms. In:
Bettini, S. (Ed.), Arthropd Venoms, pp. 317e369.
